The heterogeneity of asymmetric tau distribution is associated with an early age at onset and poor prognosis in Alzheimer’s disease

Purpose: Left-right asymmetry, an important feature of brain development, has been implicated in neurodegenerative diseases, although it’s less discussed in typical Alzheimer’s disease (AD). We sought to investigate whether asymmetric tau deposition plays a potential role in AD heterogeneity. Method...

Full description

Bibliographic Details
Main Authors: Jiaying Lu, Zhengwei Zhang, Ping Wu, Xiaoniu Liang, Huiwei Zhang, Jimin Hong, Christoph Clement, Tzu-Chen Yen, Saineng Ding, Min Wang, Zhenxu Xiao, Axel Rominger, Kuangyu Shi, Yihui Guan, Chuantao Zuo, Qianhua Zhao
Format: Article
Language:English
Published: Elsevier 2023-01-01
Series:NeuroImage: Clinical
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213158223001055
_version_ 1827925836689309696
author Jiaying Lu
Zhengwei Zhang
Ping Wu
Xiaoniu Liang
Huiwei Zhang
Jimin Hong
Christoph Clement
Tzu-Chen Yen
Saineng Ding
Min Wang
Zhenxu Xiao
Axel Rominger
Kuangyu Shi
Yihui Guan
Chuantao Zuo
Qianhua Zhao
author_facet Jiaying Lu
Zhengwei Zhang
Ping Wu
Xiaoniu Liang
Huiwei Zhang
Jimin Hong
Christoph Clement
Tzu-Chen Yen
Saineng Ding
Min Wang
Zhenxu Xiao
Axel Rominger
Kuangyu Shi
Yihui Guan
Chuantao Zuo
Qianhua Zhao
author_sort Jiaying Lu
collection DOAJ
description Purpose: Left-right asymmetry, an important feature of brain development, has been implicated in neurodegenerative diseases, although it’s less discussed in typical Alzheimer’s disease (AD). We sought to investigate whether asymmetric tau deposition plays a potential role in AD heterogeneity. Methods: Two independent cohorts consisting of patients with mild cognitive impairment due to AD and AD dementia with tau PET imaging were enrolled [the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort with 18F-Flortaucipir, the Shanghai Memory Study (SMS) cohort with 18F-Florzolotau]. Based on the absolute global tau interhemispheric differences, each cohort was divided into two groups (asymmetric versus symmetric tau distribution). The two groups were cross-sectionally compared in terms of demographic, cognitive characteristics, and pathological burden. The cognitive decline trajectories were analyzed longitudinally. Results: Fourteen (23.3%) and 42 (48.3%) patients in the ADNI and SMS cohorts showed an asymmetric tau distribution, respectively. An asymmetric tau distribution was associated with an earlier age at disease onset (proportion of early-onset AD: ADNI/SMS/combined cohorts, p = 0.093/0.026/0.001) and more severe pathological burden (i.e., global tau burden: ADNI/SMS cohorts, p < 0.001/= 0.007). And patients with an asymmetric tau distribution were characterized by a steeper cognitive decline longitudinally (i.e., the annual decline of Mini-Mental Status Examination score: ADNI/SMS/combined cohorts, p = 0.053 / 0.035 / < 0.001). Conclusions: Asymmetry in tau deposition, which may be associated with an earlier age at onset, more severe pathological burden, and a steeper cognitive decline, is potentially an important characteristic of AD heterogeneity.
first_indexed 2024-03-13T05:28:47Z
format Article
id doaj.art-c8c91bb39c3d40c780063f1e0ff35478
institution Directory Open Access Journal
issn 2213-1582
language English
last_indexed 2024-03-13T05:28:47Z
publishDate 2023-01-01
publisher Elsevier
record_format Article
series NeuroImage: Clinical
spelling doaj.art-c8c91bb39c3d40c780063f1e0ff354782023-06-15T04:55:55ZengElsevierNeuroImage: Clinical2213-15822023-01-0138103416The heterogeneity of asymmetric tau distribution is associated with an early age at onset and poor prognosis in Alzheimer’s diseaseJiaying Lu0Zhengwei Zhang1Ping Wu2Xiaoniu Liang3Huiwei Zhang4Jimin Hong5Christoph Clement6Tzu-Chen Yen7Saineng Ding8Min Wang9Zhenxu Xiao10Axel Rominger11Kuangyu Shi12Yihui Guan13Chuantao Zuo14Qianhua Zhao15Department of Nuclear Medicine &amp; PET Center, Huashan Hospital, Fudan University, Shanghai, China; Department of Nuclear Medicine, Inselspital Bern, University Hospital, University of Bern, Bern, SwitzerlandDepartment of Nuclear Medicine &amp; PET Center, Huashan Hospital, Fudan University, Shanghai, ChinaDepartment of Nuclear Medicine &amp; PET Center, Huashan Hospital, Fudan University, Shanghai, ChinaDepartment of Neurology, Huashan Hospital, Fudan University, Shanghai, ChinaDepartment of Nuclear Medicine &amp; PET Center, Huashan Hospital, Fudan University, Shanghai, ChinaDepartment of Nuclear Medicine, Inselspital Bern, University Hospital, University of Bern, Bern, SwitzerlandDepartment of Nuclear Medicine, Inselspital Bern, University Hospital, University of Bern, Bern, SwitzerlandAPRINOIA Therapeutics Co., Ltd, Suzhou, ChinaDepartment of Neurology, Huashan Hospital, Fudan University, Shanghai, ChinaShanghai Institute for Advanced Communication and Data Science, Shanghai University, Shanghai, China; Department of Informatics, Technische Universität München, Munich, GermanyDepartment of Neurology, Huashan Hospital, Fudan University, Shanghai, ChinaDepartment of Nuclear Medicine, Inselspital Bern, University Hospital, University of Bern, Bern, SwitzerlandDepartment of Nuclear Medicine, Inselspital Bern, University Hospital, University of Bern, Bern, Switzerland; Department of Informatics, Technische Universität München, Munich, GermanyDepartment of Nuclear Medicine &amp; PET Center, Huashan Hospital, Fudan University, Shanghai, China; National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China; National Center for Neurological Disorders, Huashan Hospital, Fudan University, Shanghai, China; Corresponding authors at: Department of Nuclear Medicine &amp; PET Center, Huashan Hospital, Fudan University, 518 East Wuzhong Road, Shanghai 200235, China (C. Zuo, Y. Guan); Department of Neurology, Huashan Hospital, Fudan University, 12 Middle Wulumuqi Road, Shanghai 200040, China (Q. Zhao).Department of Nuclear Medicine &amp; PET Center, Huashan Hospital, Fudan University, Shanghai, China; National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China; National Center for Neurological Disorders, Huashan Hospital, Fudan University, Shanghai, China; Corresponding authors at: Department of Nuclear Medicine &amp; PET Center, Huashan Hospital, Fudan University, 518 East Wuzhong Road, Shanghai 200235, China (C. Zuo, Y. Guan); Department of Neurology, Huashan Hospital, Fudan University, 12 Middle Wulumuqi Road, Shanghai 200040, China (Q. Zhao).Department of Neurology, Huashan Hospital, Fudan University, Shanghai, China; National Clinical Research Center for Aging and Medicine, Huashan Hospital, Fudan University, Shanghai, China; National Center for Neurological Disorders, Huashan Hospital, Fudan University, Shanghai, China; MOE Frontiers Center for Brain Science, Fudan University, Shanghai, China; Corresponding authors at: Department of Nuclear Medicine &amp; PET Center, Huashan Hospital, Fudan University, 518 East Wuzhong Road, Shanghai 200235, China (C. Zuo, Y. Guan); Department of Neurology, Huashan Hospital, Fudan University, 12 Middle Wulumuqi Road, Shanghai 200040, China (Q. Zhao).Purpose: Left-right asymmetry, an important feature of brain development, has been implicated in neurodegenerative diseases, although it’s less discussed in typical Alzheimer’s disease (AD). We sought to investigate whether asymmetric tau deposition plays a potential role in AD heterogeneity. Methods: Two independent cohorts consisting of patients with mild cognitive impairment due to AD and AD dementia with tau PET imaging were enrolled [the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort with 18F-Flortaucipir, the Shanghai Memory Study (SMS) cohort with 18F-Florzolotau]. Based on the absolute global tau interhemispheric differences, each cohort was divided into two groups (asymmetric versus symmetric tau distribution). The two groups were cross-sectionally compared in terms of demographic, cognitive characteristics, and pathological burden. The cognitive decline trajectories were analyzed longitudinally. Results: Fourteen (23.3%) and 42 (48.3%) patients in the ADNI and SMS cohorts showed an asymmetric tau distribution, respectively. An asymmetric tau distribution was associated with an earlier age at disease onset (proportion of early-onset AD: ADNI/SMS/combined cohorts, p = 0.093/0.026/0.001) and more severe pathological burden (i.e., global tau burden: ADNI/SMS cohorts, p < 0.001/= 0.007). And patients with an asymmetric tau distribution were characterized by a steeper cognitive decline longitudinally (i.e., the annual decline of Mini-Mental Status Examination score: ADNI/SMS/combined cohorts, p = 0.053 / 0.035 / < 0.001). Conclusions: Asymmetry in tau deposition, which may be associated with an earlier age at onset, more severe pathological burden, and a steeper cognitive decline, is potentially an important characteristic of AD heterogeneity.http://www.sciencedirect.com/science/article/pii/S2213158223001055AsymmetryTauPositron emission tomographyAlzheimer’s diseaseAgePrognosis
spellingShingle Jiaying Lu
Zhengwei Zhang
Ping Wu
Xiaoniu Liang
Huiwei Zhang
Jimin Hong
Christoph Clement
Tzu-Chen Yen
Saineng Ding
Min Wang
Zhenxu Xiao
Axel Rominger
Kuangyu Shi
Yihui Guan
Chuantao Zuo
Qianhua Zhao
The heterogeneity of asymmetric tau distribution is associated with an early age at onset and poor prognosis in Alzheimer’s disease
NeuroImage: Clinical
Asymmetry
Tau
Positron emission tomography
Alzheimer’s disease
Age
Prognosis
title The heterogeneity of asymmetric tau distribution is associated with an early age at onset and poor prognosis in Alzheimer’s disease
title_full The heterogeneity of asymmetric tau distribution is associated with an early age at onset and poor prognosis in Alzheimer’s disease
title_fullStr The heterogeneity of asymmetric tau distribution is associated with an early age at onset and poor prognosis in Alzheimer’s disease
title_full_unstemmed The heterogeneity of asymmetric tau distribution is associated with an early age at onset and poor prognosis in Alzheimer’s disease
title_short The heterogeneity of asymmetric tau distribution is associated with an early age at onset and poor prognosis in Alzheimer’s disease
title_sort heterogeneity of asymmetric tau distribution is associated with an early age at onset and poor prognosis in alzheimer s disease
topic Asymmetry
Tau
Positron emission tomography
Alzheimer’s disease
Age
Prognosis
url http://www.sciencedirect.com/science/article/pii/S2213158223001055
work_keys_str_mv AT jiayinglu theheterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT zhengweizhang theheterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT pingwu theheterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT xiaoniuliang theheterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT huiweizhang theheterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT jiminhong theheterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT christophclement theheterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT tzuchenyen theheterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT sainengding theheterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT minwang theheterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT zhenxuxiao theheterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT axelrominger theheterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT kuangyushi theheterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT yihuiguan theheterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT chuantaozuo theheterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT qianhuazhao theheterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT jiayinglu heterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT zhengweizhang heterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT pingwu heterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT xiaoniuliang heterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT huiweizhang heterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT jiminhong heterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT christophclement heterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT tzuchenyen heterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT sainengding heterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT minwang heterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT zhenxuxiao heterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT axelrominger heterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT kuangyushi heterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT yihuiguan heterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT chuantaozuo heterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease
AT qianhuazhao heterogeneityofasymmetrictaudistributionisassociatedwithanearlyageatonsetandpoorprognosisinalzheimersdisease